GlassScriptPhysician profile
Bertha Campos
NPI 1255436366
$3,199.03
in general payments reported to CMS, 2019-2025
19 companies · $1,103 in 2025
The $1,103 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.92 · 2022: $280 · 2023: $802 · 2024: $984 · 2025: $1,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $856.14 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $513.75 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $313.46 | 2023-2025 | |
| Amgen INC. | $272.50 | 2023-2025 | Repatha, Repatha, Otezla |
| Abbott Laboratories | $243.56 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $178.64 | 2022-2025 | Arexvy, Shingrix |
| Novo Nordisk INC | $173.90 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $133.32 | 2021-2025 | |
| Exact Sciences Corporation | $127.82 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $106.08 | 2023 | |
| Merck Sharp & Dohme LLC | $64.37 | 2022-2025 | Capvaxive, Gardasil 9, Gardasil |
| Dynavax Technologies Corporation | $50.88 | 2024-2025 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $45.55 | 2023 | Spravato |
| Sanofi Pasteur INC. | $24.38 | 2025 | |
| Hologic Sales and Service, LLC | $22.23 | 2024 | Thinprep 2000 Processor, Aptima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.43 | 2023 | Accrufer |
| Ibsa Pharma INC. | $20.00 | 2025 | Flector, Licart, Tirosint |
| Amarin Pharma, INC. | $16.51 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.51 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertha Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.